Science and Discovery

Obesity

4 articles

Abstract representation of a human torso showing significant reduction in liver and belly fat due to a new pharmaceutical drug.
Cosmos & Space

Boehringer Ingelheim drug slashes liver and belly fat

In Phase 3 trials, Boehringer Ingelheim's experimental obesity drug, survodutide, helped recipients shed up to 17% of their body weight over 76 weeks, crucially preserving muscle mass.

David Grossman·June 8, 2026
A scientist in a modern lab examining a glowing molecular model, representing Lilly's new oral obesity drug aleniglipron and its promising safety profile.
Cosmos & Space

Lilly's oral obesity drug shows promising safety and tolerability

Lilly's experimental oral obesity drug, aleniglipron, helped patients lose up to 12.

Aram Sarkisian·June 7, 2026
Doctor reviewing BMI chart contrasted with diverse individuals enjoying healthy lifestyles, highlighting the limitations of BMI in assessing true health.
Health & Medicine

Obesity Disease Label Doesn't Fit All, BMI Imperfectly Assesses Health

A study published in the Annals of Family Medicine on June 24, 2025, found the Body Mass Index (BMI) to be entirely unreliable in predicting 15-year mortality risk from any cause, including heart dise

David Grossman·June 1, 2026
A glowing quintuple agonist molecule in a futuristic lab, symbolizing a breakthrough in obesity and diabetes treatment for mice.
Cosmos & Space

New Quintuple Agonist Targets GLP-1R, GIPR, PPARs in Mice

In mouse models, an experimental obesity and diabetes drug called GLP-1-GIP-Lani not only corrected obesity and diabetes but also significantly outperformed semaglutide in lowering body weight, food i

Aram Sarkisian·May 18, 2026